2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow vaborbactam: new trials by email Literature Review of vaborbactam trials Research Report on vaborbactam
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy/Safety of Meropenem-Vaborbactam Compared to Piperacillin-Tazobactam in Adults With cUTI and AP Meropenem-Vaborbactam, Piperacillin-Tazobactam, Levofloxacin - Urinary Tract Infection Complicated, Acute Pyelonephritis | Phase 3 | Completed | Melinta Therapeutics, Inc. | 550 | 2014-11-20 | 2018-06-11 |
| Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections in Adults Vabomere, Best Available Therapy - Urinary Tract Infection Complicated, Acute Pyelonephritis | Phase 3 | Completed | Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) | 77 | 2014-07-01 | 2019-03-04 |
Bacteremia (1) · Intraabdominal Infections (1)
Melinta Therapeutics, Inc. (1) · Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) (1)
Brazil (2) · Greece (2) · Italy (2) · United States (2) · Argentina (1) · Belarus (1) · Bulgaria (1) · Colombia (1) · Czechia (1) · Hungary (1) · Israel (1) · Peru (1) · Poland (1) · Romania (1) · Slovakia (1)
Karen Fusaro (2) · Keith Kaye (2)